Next-generation sequencing reveals mutations in RB1, CDK4 and TP53 that may promote chemo-resistance to palbociclib in ovarian cancer
about
Next-generation sequencing reveals mutations in RB1, CDK4 and TP53 that may promote chemo-resistance to palbociclib in ovarian cancer
description
scientific article published on 30 May 2019
@en
name
Next-generation sequencing rev ...... palbociclib in ovarian cancer
@en
type
label
Next-generation sequencing rev ...... palbociclib in ovarian cancer
@en
prefLabel
Next-generation sequencing rev ...... palbociclib in ovarian cancer
@en
P2093
P356
P1476
Next-generation sequencing rev ...... palbociclib in ovarian cancer
@en
P2093
Fadi Farhat
Fatima Saleh
Shafka Assaad
P356
10.1515/DMPT-2018-0027
P577
2019-05-30T00:00:00Z